Perinatal factors, female breast cancer, and associated risk factors in Puerto Rico: evidence from the Atabey epidemiology of breast cancer study

Mattick, Lindsey J; Nazario, Cruz M.; Rosario-Rosado, Rosa V.; Schelske‐Santos, Michelle; Mansilla-Rivera, Imar; Ramírez-Marrero, Farah A.; Nie, Jing; Freudenheim, Jo L.

doi:10.1007/s10552-021-01531-0

Cited by 1 publication

(1 citation statement)

References 51 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…According to China's cancer statistics report (Cao et al, 2021; Chen et al, 2022; Xia et al, 2022), the incidence of breast cancer increases by 3%–4% every year, the growth rate is two to three times of the world average level, and this trend will continue in the future. The incidence of breast cancer is high, but with the popularization of early screening and the continuous improvement of comprehensive treatment technology, the mortality rate of breast cancer patients in most countries and regions can remain stable, or even fall steadily (Boere et al, 2022; Mattick et al, 2022; Wilkinson & Gathani, 2022). According to the National Institutes of Health statistics from 2010 to 2016, the 5‐year survival rate of breast cancer patients after surgery is 90%, and 82% in China (Zeng et al, 2018).…”

Section: Introductionmentioning

confidence: 99%

Return‐to‐work self‐efficacy questionnaire: Cross‐cultural adaptation and validation in China

Wang

Zhu

et al. 2023

Nursing Open

View full text Add to dashboard Cite

Breast cancer has become the most common malignant tumour in Chinese women, accounting for 12.2% of newly diagnosed breast cancer worldwide (Chen et al., 2022;Fan et al., 2014). According to China's cancer statistics report (Cao et al., 2021;Chen et al., 2022;Xia et al., 2022), the incidence of breast cancer increases by 3%-4% every year, the growth rate is two to three times of the world average level, and this trend will continue in the future. The incidence of breast cancer is high, but with the popularization of early screening and the continuous improvement of comprehensive treatment technology, the mortality rate of breast cancer patients in most countries and regions can remain stable, or even fall steadily (Boere et al., 2022;Mattick et al., 2022;Wilkinson & Gathani, 2022). According to the National Institutes of Health statistics from 2010 to 2016, the 5-year survival rate of breast cancer patients after surgery is 90%, and 82% in China (Zeng et al., 2018). It can be seen that breast cancer patients have better cure prospects and longer, higher quality survival (Fei et al., 2015).In China, most breast cancer patients are middle-aged and young women, who are at an important stage of career development (Liu

show abstract